table of content
1 Study Coverage
1.1 Ocular Drug Delivery Product Introduction
1.2 Global Ocular Drug Delivery Outlook 2017 VS 2022 VS 2028
1.2.1 Global Ocular Drug Delivery Sales in US$ Million for the Year 2017-2028
1.2.2 Global Ocular Drug Delivery Sales in Volume for the Year 2017-2028
1.3 United States Ocular Drug Delivery Outlook 2017 VS 2022 VS 2028
1.3.1 United States Ocular Drug Delivery Sales in US$ Million for the Year 2017-2028
1.3.2 United States Ocular Drug Delivery Sales in Volume for the Year 2017-2028
1.4 Ocular Drug Delivery Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Ocular Drug Delivery in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Ocular Drug Delivery Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Ocular Drug Delivery Market Dynamics
1.5.1 Ocular Drug Delivery Industry Trends
1.5.2 Ocular Drug Delivery Market Drivers
1.5.3 Ocular Drug Delivery Market Challenges
1.5.4 Ocular Drug Delivery Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Ocular Drug Delivery Market Segment by Type
2.1.1 Ocular Insert
2.1.2 Iontophoresis
2.1.3 Intraocular Implants
2.1.4 In Situ Gel & Punctal Plugs
2.1.5 Others
2.2 Global Ocular Drug Delivery Market Size by Type
2.2.1 Global Ocular Drug Delivery Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Ocular Drug Delivery Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Ocular Drug Delivery Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Ocular Drug Delivery Market Size by Type
2.3.1 United States Ocular Drug Delivery Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Ocular Drug Delivery Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Ocular Drug Delivery Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Ocular Drug Delivery Market Segment by Application
3.1.1 Hospitals
3.1.2 Ambulatory Surgical Centers
3.1.3 Ophthalmic Clinics
3.1.4 Homecare Settings
3.2 Global Ocular Drug Delivery Market Size by Application
3.2.1 Global Ocular Drug Delivery Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Ocular Drug Delivery Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Ocular Drug Delivery Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Ocular Drug Delivery Market Size by Application
3.3.1 United States Ocular Drug Delivery Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Ocular Drug Delivery Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Ocular Drug Delivery Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Ocular Drug Delivery Competitor Landscape by Company
4.1 Global Ocular Drug Delivery Market Size by Company
4.1.1 Top Global Ocular Drug Delivery Manufacturers Ranked by Revenue (2021)
4.1.2 Global Ocular Drug Delivery Revenue by Manufacturer (2017-2022)
4.1.3 Global Ocular Drug Delivery Sales by Manufacturer (2017-2022)
4.1.4 Global Ocular Drug Delivery Price by Manufacturer (2017-2022)
4.2 Global Ocular Drug Delivery Concentration Ratio (CR)
4.2.1 Ocular Drug Delivery Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Ocular Drug Delivery in 2021
4.2.3 Global Ocular Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Ocular Drug Delivery Manufacturing Base Distribution, Product Type
4.3.1 Global Ocular Drug Delivery Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Ocular Drug Delivery Product Type
4.3.3 Date of International Manufacturers Enter into Ocular Drug Delivery Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Ocular Drug Delivery Market Size by Company
4.5.1 Top Ocular Drug Delivery Players in United States, Ranked by Revenue (2021)
4.5.2 United States Ocular Drug Delivery Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Ocular Drug Delivery Sales by Players (2020, 2021 & 2022)
5 Global Ocular Drug Delivery Market Size by Region
5.1 Global Ocular Drug Delivery Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Ocular Drug Delivery Market Size in Volume by Region (2017-2028)
5.2.1 Global Ocular Drug Delivery Sales in Volume by Region: 2017-2022
5.2.2 Global Ocular Drug Delivery Sales in Volume Forecast by Region (2023-2028)
5.3 Global Ocular Drug Delivery Market Size in Value by Region (2017-2028)
5.3.1 Global Ocular Drug Delivery Sales in Value by Region: 2017-2022
5.3.2 Global Ocular Drug Delivery Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Ocular Drug Delivery Market Size YoY Growth 2017-2028
6.1.2 North America Ocular Drug Delivery Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Ocular Drug Delivery Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Ocular Drug Delivery Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Ocular Drug Delivery Market Size YoY Growth 2017-2028
6.3.2 Europe Ocular Drug Delivery Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Ocular Drug Delivery Market Size YoY Growth 2017-2028
6.4.2 Latin America Ocular Drug Delivery Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Ocular Drug Delivery Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Ocular Drug Delivery Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 OCULAR THERAPEUTIX, INC
7.1.1 OCULAR THERAPEUTIX, INC Corporation Information
7.1.2 OCULAR THERAPEUTIX, INC Description and Business Overview
7.1.3 OCULAR THERAPEUTIX, INC Ocular Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.1.4 OCULAR THERAPEUTIX, INC Ocular Drug Delivery Products Offered
7.1.5 OCULAR THERAPEUTIX, INC Recent Development
7.2 Alimera Sciences
7.2.1 Alimera Sciences Corporation Information
7.2.2 Alimera Sciences Description and Business Overview
7.2.3 Alimera Sciences Ocular Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Alimera Sciences Ocular Drug Delivery Products Offered
7.2.5 Alimera Sciences Recent Development
7.3 Allergan, Plc
7.3.1 Allergan, Plc Corporation Information
7.3.2 Allergan, Plc Description and Business Overview
7.3.3 Allergan, Plc Ocular Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Allergan, Plc Ocular Drug Delivery Products Offered
7.3.5 Allergan, Plc Recent Development
7.4 EyeGate Pharma
7.4.1 EyeGate Pharma Corporation Information
7.4.2 EyeGate Pharma Description and Business Overview
7.4.3 EyeGate Pharma Ocular Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.4.4 EyeGate Pharma Ocular Drug Delivery Products Offered
7.4.5 EyeGate Pharma Recent Development
7.5 Valeant Pharmaceuticals International, Inc
7.5.1 Valeant Pharmaceuticals International, Inc Corporation Information
7.5.2 Valeant Pharmaceuticals International, Inc Description and Business Overview
7.5.3 Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Products Offered
7.5.5 Valeant Pharmaceuticals International, Inc Recent Development
7.6 Envisia Therapeutics
7.6.1 Envisia Therapeutics Corporation Information
7.6.2 Envisia Therapeutics Description and Business Overview
7.6.3 Envisia Therapeutics Ocular Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Envisia Therapeutics Ocular Drug Delivery Products Offered
7.6.5 Envisia Therapeutics Recent Development
7.7 Clearside Biomedical
7.7.1 Clearside Biomedical Corporation Information
7.7.2 Clearside Biomedical Description and Business Overview
7.7.3 Clearside Biomedical Ocular Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Clearside Biomedical Ocular Drug Delivery Products Offered
7.7.5 Clearside Biomedical Recent Development
7.8 Graybug Vision Inc
7.8.1 Graybug Vision Inc Corporation Information
7.8.2 Graybug Vision Inc Description and Business Overview
7.8.3 Graybug Vision Inc Ocular Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Graybug Vision Inc Ocular Drug Delivery Products Offered
7.8.5 Graybug Vision Inc Recent Development
7.9 Taiwan Liposome Company
7.9.1 Taiwan Liposome Company Corporation Information
7.9.2 Taiwan Liposome Company Description and Business Overview
7.9.3 Taiwan Liposome Company Ocular Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Taiwan Liposome Company Ocular Drug Delivery Products Offered
7.9.5 Taiwan Liposome Company Recent Development
7.10 Santen Pharmaceutical
7.10.1 Santen Pharmaceutical Corporation Information
7.10.2 Santen Pharmaceutical Description and Business Overview
7.10.3 Santen Pharmaceutical Ocular Drug Delivery Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Santen Pharmaceutical Ocular Drug Delivery Products Offered
7.10.5 Santen Pharmaceutical Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Ocular Drug Delivery Industry Chain Analysis
8.2 Ocular Drug Delivery Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Ocular Drug Delivery Distributors
8.3 Ocular Drug Delivery Production Mode & Process
8.4 Ocular Drug Delivery Sales and Marketing
8.4.1 Ocular Drug Delivery Sales Channels
8.4.2 Ocular Drug Delivery Distributors
8.5 Ocular Drug Delivery Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
